• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CXS
Click for more information
0.00% 70.0¢

CHEMGENEX PHARMACEUTICALS LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CXS
Ann: Notice of Compulsory Acquisition 		24/12/11 1 808
24/12/11 Last post  ddzx Comments Created with Sketch.  1  Views Created with Sketch.  808 
CXS
Ann: Removal from Official List close of trading 		22/07/11 0 519
22/07/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  519 
CXS
Ann: Change in substantial holding 		21/07/11 0 561
21/07/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  561 
CXS
diagnostic tests used with targeted drug thera 		13/07/11 0 427
13/07/11 Last post  TitusPullo Comments Created with Sketch.  0  Views Created with Sketch.  427 
CXS
Ann: Change in substantial holding 		12/07/11 0 568
12/07/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  568 
CXS
Ann: Board Changes and Director's Interest No 		01/07/11 0 475
01/07/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  475 
CXS
Ann: Suspension at close of trading 21/6/11 		21/06/11 0 489
21/06/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  489 
CXS
Ann: Notice of compulsory acquisition following T 		16/06/11 0 320
16/06/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  320 

See All Discussions arrow Created with Sketch.

Top Stories

Scientific conference spotlights PYC's work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.